Abstract:Macroautophagy/autophagy is an evolutionarily conserved pathway responsible for clearing cytosolic aggregated proteins, damaged organelles or invading microorganisms. Dysfunctional autophagy leads to pathological accumulation of the cargo, which has been linked to a range of human diseases, including neurodegenerative diseases, infectious and autoimmune diseases and various forms of cancer. Cumulative work in animal models, application of genetic tools and pharmacologically active compounds, has suggested the potential therapeutic value of autophagy modulation in disease, as diverse as Huntington, Salmonella infection, or pancreatic cancer. Autophagy activation versus inhibition strategies are being explored, while the role of autophagy in pathophysiology is being studied in parallel. However, the progress of preclinical and clinical development of autophagy modulators has been greatly hampered by the paucity of selective pharmacological agents and biomarkers to dissect their precise impact on various forms of autophagy and cellular responses. Here, we summarize established and new strategies in autophagy-related drug discovery and indicate a path toward establishing a more efficient discovery of autophagy-selective pharmacological agents. With this knowledge at hand, modern concepts for therapeutic exploitation of autophagy might become more plausible.Abbreviations: ALS: amyotrophic lateral sclerosis; AMPK: AMP-activated protein kinase; ATG: autophagy-related gene; AUTAC: autophagy-targeting chimera; CNS: central nervous system; CQ: chloroquine; GABARAP: gamma-aminobutyric acid type A receptor-associated protein; HCQ: hydroxychloroquine; LYTAC: lysosome targeting chimera; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MTOR: mechanistic target of rapamycin kinase; NDD: neurodegenerative disease; PDAC: pancreatic ductal adenocarcinoma; PE: phosphatidylethanolamine; PIK3C3/VPS34: phosphatidylinositol 3-kinase catalytic subunit type 3; PtdIns3K: class III phosphatidylinositol 3-kinase; PtdIns3P: phosphatidylinositol 3-phosphate; PROTAC: proteolysis-targeting chimera; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; SQSTM1/p62: sequestosome 1; ULK1: unc-51 like autophagy activating kinase 1.

Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds

Recent Advances of Vacuolar Protein-Sorting 34 Inhibitors Targeting Autophagy

Regulatory Mechanisms Governing the Autophagy-Initiating VPS34 Complex and Its inhibitors

Two-layer Regulation of PAQR3 on ATG14-linked Class III PtdIns3K Activation Upon Glucose Starvation

Development of small-molecule inhibitors that target PI3Kβ

PAQR3 Controls Autophagy by Integrating AMPK Signaling to Enhance ATG14L-associated PI3K Activity.

Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies

VPS34 Acetylation Controls Its Lipid Kinase Activity and the Initiation of Canonical and Non-canonical Autophagy.

VPS34 complexes from a structural perspective

VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress

Class III PI3K Positively Regulates Platelet Activation and Thrombosis Via PI(3)P-Directed Function of NADPH Oxidase

Autophagy and new strategy for cancer prevention and treatment

VMP1: a multifaceted regulator of cellular homeostasis with implications in disease pathology

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease

Targeting autophagy drug discovery: Targets, indications and development trends

Drug discovery by targeting the protein‒protein interactions involved in autophagy

Targeting Autophagy-Related Protein Kinases for Potential Therapeutic Purpose

Targeting autophagy with small-molecule activators for potential therapeutic purposes

Targeting autophagy in disease: established and new strategies

Unveiling the role of VPS34 kinase domain dynamics in regulation of the autophagic PI3K complex

Molecular Modulators and Receptors of Selective Autophagy: Disease Implication and Identification Strategies